Differential Pricing: Can it Solve the Access to Medicines Problem?

Professor Adrian Towse is Director Emeritus of the Office of Health Economics in the UK and has held visiting positions at the University of Oxford, London School of Economics and the University of York. His current research includes incentives for new drugs and vaccines to tackle antimicrobial resistance, the use of ‘risk-sharing’ arrangements between healthcare payers and pharmaceutical companies, including value-based pricing approaches.